European Journal of Dermatology
MENUAnti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer Volume 24, numéro 4, Juillet-Août
Illustrations
1 Department of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
2 Department of Dermatology, Higashiosaka City General Hospital, Osaka, Japan
3 Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
- DOI : 10.1684/ejd.2014.2381
- Page(s) : 490-1
- Année de parution : 2014
Dermatomyositis (DM) is an autoimmune inflammatory disease often associated with internal malignancy and interstitial lung disease. The latter is found in about 50% of patients with DM and is a life-threatening complication of the disease [1]. Rapidly progressive interstitial lung disease (RP-ILD) associated with clinically amyopathic dermatomyositis (CADM) is often lethal, despite treatment by corticosteroid therapy combined with immunosuppressive drugs [2].A number of autoantibodies can be detected [...]